Skip to Content

K U 725 (Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg)

Pill with imprint K U 725 is Yellow, Figure eight-shape and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg. It is supplied by Cobalt Laboratories Inc.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for K U 725

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
K U 725
Strength
25 mg / 15 mg
Color
Yellow
Size
14.00 mm
Shape
Figure eight-shape
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cobalt Laboratories Inc
National Drug Code (NDC)
16252-0614

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.